Overview

Vinorelbine for Recurrent ACLC

Status:
Unknown status

Trial end date:
2020-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficiency and safety of vinorelbine in the treatment of relapsed / advanced ALCL in children and adolescents.

Phase:

Phase 2

Details

Lead Sponsor:

Children's Cancer Group, China

Treatments:

Vinblastine
Vinorelbine